Stockreport

JMP Backs Crinetics Pharmaceuticals, Inc. (CRNX) With Big Upside Post-Approval [Yahoo! Finance]

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report
PDF reaffirmed their ‘Market Outperform' rating on Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), while raising the price target to $143 from $86, implying an upside potenti [Read more]